POLR1E expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.179400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.356400E-01
Normal-vs-Stage2
5.802400E-01
Normal-vs-Stage3
2.586800E-01
Normal-vs-Stage4
5.229600E-01
Stage1-vs-Stage2
8.877200E-01
Stage1-vs-Stage3
3.059200E-01
Stage1-vs-Stage4
2.008000E-01
Stage2-vs-Stage3
3.476800E-01
Stage2-vs-Stage4
1.059850E-01
Stage3-vs-Stage4
9.520200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.587800E-01
Normal-vs-AfricanAmerican
4.871400E-01
Normal-vs-Asian
9.554400E-02
Caucasian-vs-AfricanAmerican
6.941000E-01
Caucasian-vs-Asian
8.539500E-02
AfricanAmerican-vs-Asian
3.138600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.655200E-01
Normal-vs-Female
5.565400E-01
Male-vs-Female
7.995400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.355800E-01
Normal-vs-Age(41-60Yrs)
7.602200E-01
Normal-vs-Age(61-80Yrs)
5.263200E-01
Normal-vs-Age(81-100Yrs)
9.637200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.324400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.716800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.108400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.071400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.294400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.664000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.937400E-01
Normal-vs-Daily Drinker
6.166800E-01
Normal-vs-Weekly Drinker
9.689000E-01
Normal-vs-Occasional Drinker
6.262000E-01
Normal-vs-Social Drinker
8.537800E-01
Non Drinker-vs-Daily Drinker
4.977800E-01
Non Drinker-vs-Weekly Drinker
1.161030E-01
Non Drinker-vs-Occasional Drinker
5.207800E-01
Non Drinker-vs-Social Drinker
2.258600E-01
Daily Drinker-vs-Weekly Drinker
3.525200E-01
Daily Drinker-vs-Occasional Drinker
9.963600E-01
Daily Drinker-vs-Social Drinker
5.720000E-01
Weekly Drinker-vs-Occasional Drinker
3.799000E-01
Weekly Drinker-vs-Social Drinker
7.170200E-01
Occasional Drinker-vs-Social Drinker
5.938600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.820600E-01
Normal-vs-Grade 2
8.329600E-01
Normal-vs-Grade 3
7.969800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.083400E-01
Grade 1-vs-Grade 3
7.705600E-01
Grade 1-vs-Grade 4
7.820600E-01
Grade 2-vs-Grade 3
3.851200E-01
Grade 2-vs-Grade 4
8.329600E-01
Grade 3-vs-Grade 4
7.969800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.616000E-01
Normal-vs-NonDiabetic
5.550200E-01
Diabetic-vs-NonDiabetic
8.780600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.848360E-01
Normal-vs-NoPancreatitis
6.640800E-01
Pancreatitis-vs-NoPancreatitis
1.472770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.791000E-01
Normal-vs-N1
6.182800E-01
N0-vs-N1
8.310400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.734000E-01
Normal-vs-TP53-NonMutant
8.356600E-01
TP53-Mutant-vs-TP53-NonMutant
2.770800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
